950 — Lees Pharmaceutical Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- HK$712.49m
- HK$527.29m
- HK$1.44bn
Annual cashflow statement for Lees Pharmaceutical Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 1,969 | 67.9 | 30.8 | 98.1 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -1,902 | 71.6 | 28.1 | 70.5 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.45 | -8.36 | -98.3 | -74.4 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 211 | 284 | 110 | 242 | — |
| Capital Expenditures | -371 | -214 | -160 | -208 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.443 | -42.2 | 14.5 | 17.3 | — |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -370 | -256 | -145 | -190 | — |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 61 | -129 | 13.4 | -1.96 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -97.7 | -88.2 | -21.8 | 49.3 | — |